Medical News

RSS

US WorldMeds announces acquisition of Solstice Neurosciences for $35M

US WorldMeds, LLC, a Kentucky-based specialty pharmaceutical company that develops unique products to address unmet medical needs, today announced it has acquired Solstice Neurosciences, Inc. for $35 million. The acquisition expands US WorldMeds' operations, adds to the company's growing portfolio of products and enhances the company's ability to create and deliver high-quality specialty pharmaceutical products to its targeted global markets.

16 Aug 2010

Delegates explore agricultural cooperation, expanded ties at two-day China-Africa Agricultural Forum

Chinese and African officials concluded the China-Africa Agricultural Forum in Beijing on Thursday, which explored possibilities for agricultural cooperation and addressed food security issues, Xinhua reports.

16 Aug 2010

Stockholders of Allscripts, Eclipsys approve fusion of two companies

Allscripts-Misys Healthcare Solutions, Inc. (Allscripts), the leading provider of clinical software, information and connectivity solutions for physicians, and Eclipsys Corporation ,a leading enterprise provider of solutions and services for hospitals and clinicians, today announced that stockholders of each company approved the merger of Allscripts and Eclipsys.

16 Aug 2010

FDA's labeling of Ella as 'Emergency Contraceptive' misleading, says FRC

Today the Food and Drug Administration (FDA) approved Ella, a drug that can cause abortions but is misleadingly labeled as a more effective "Emergency Contraceptive."

16 Aug 2010

MeCP2 protein regulates properties of psychostimulant drugs: Research

When a certain protein is mutated or missing, symptoms of the neurodevelopmental disorder Rett syndrome arise, causing a gradual loss of brain function during early development.This fact led Duke University Medical Center researchers to test a theory that the protein might also contribute to nerve-cell connection (synapse) changes in a fully formed adult mouse brain when exposed to psychostimulant use.

16 Aug 2010

Medicare fraudsters shift targets a la "whack-a-mole"

The Economist: In an effort to staunch the flow of up to $60 billion a year to Medicare fraudsters, federal officials are launching a series of new safeguards that target program areas favored by the con artists. "The Department of Health and Human Services is setting up data systems to monitor payments. A telephone-monitoring programme, with voice-recognition, will verify that health-care workers really are making home visits.

16 Aug 2010

Aeolus Pharmaceuticals second quarter 2010 net loss increases to $0.10 per share

Aeolus Pharmaceuticals, Inc. announced today financial results for the three months ended June 30, 2010. The Company reported a net loss of $4,623,000, or $0.10 per share, compared to a net loss of $426,000, or $0.01 per share, for the three months ended June 30, 2009. The third quarter 2010 results include a non-cash financing and change in valuation charge of $3,856,000. Loss from operations for the three months ended June 30, 2010 were $750,000 compared to $445,000 for the three months ended June 30, 2009.

16 Aug 2010

Scientists replace human gene to preserve photoreceptor function in retinal degeneration

The easy accessibility of the eye and the established link between specific genetic defects and ocular disorders offer hope for using gene therapy to provide long-term therapeutic benefit. Two reports in the current issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc., describe the effective replacement of a human gene to preserve photoreceptor function in a mouse model of severe retinal degeneration. The articles are available free online.

16 Aug 2010

Allscripts commences public offering on behalf of Misys plc

Allscripts-Misys Healthcare Solutions, Inc., the leading provider of clinical software, information and connectivity solutions for physicians, today announced that it has commenced an underwritten public offering of 25,000,000 shares of its common stock on behalf of certain wholly-owned subsidiaries of Misys plc, Allscripts' majority stockholder.

16 Aug 2010

Inovio Pharmaceuticals 2010 second quarter net loss decreases

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2010.Total revenue was $1.1 million and $2.5 million for the three and six months ended June 30, 2010, compared to $2.5 million and $2.9 million for the three and six months ended June 30, 2009, respectively.

16 Aug 2010

National Mentor Holdings third-quarter revenue increases 6.1% to $259.7 million

National Mentor Holdings, Inc. today announced its financial results for the third quarter ended June 30, 2010.

16 Aug 2010

Medicare disability recipient dies of brain tumor after having coverage interrupted

Milwaukee Journal Sentinel: "Paula Oertel, whose brain tumor disappeared for nine years while she was on an expensive drug and returned after she temporarily lost her insurance coverage, has died as a result of the tumor spreading through her brain. The interruption of her Medicare coverage of the drug directly contributed to her death, contends her doctor, Mark Malkin, chief of neuro-oncology at Froedtert Hospital.

16 Aug 2010

Nymox second-quarter net loss increases to $1.75 million

Nymox Pharmaceutical Corporation announced today its financial results for the second quarter of 2010. Nymox reported a net loss of $1,745,798, or $0.05 per share for the quarter and $3,015,348, or $0.10 per share for the six months ending June 30, 2010, compared to $1,220,152, or $0.04 per share for the quarter and $2,224,411, or $0.07 per share for the six months ending June 30, 2009. Net losses include stock compensation charges for the quarter of $245,245 in 2010 and $248,886 in 2009 and for the six months ending June 30 of $440,465 in 2010 and $558,536 in 2009.

16 Aug 2010

Insurers defend limited-benefit health policies in fight over proposed restrictions

Kaiser Health News staff writer Julie Appleby, in collaboration with USA Today, writes: "A few months into a new job as a contract engineer, Jim Arey was stunned by an $8,000 bill he received for two doctor-administered infusions of an expensive drug he needs regularly. That's when the Columbia, Md., man learned that the insurance provided through his placement firm capped doctor office care at $2,000 a year.

16 Aug 2010

Treatment for diabetics cost U.S. hospitals 25% more than stays for non-diabetics

U.S. hospitals spent $83 billion in 2008 caring for people with diabetes, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. In that year, nearly one of every five hospitalizations involved a person with diabetes.

16 Aug 2010

Psychological stress in middle age can lead to dementia: Research

Psychological stress in middle age could lead to the development of dementia later in life, especially Alzheimer's disease, reveals research from the University of Gothenburg, Sweden. Based on data from a study which followed women for 35 years, this is the first research in Sweden to indicate a link between stress and dementia.

16 Aug 2010

New T cell engineering approach can improve success rate of immune-cell therapies

Clinical trials using patients' own immune cells to target tumors have yielded promising results. However, this approach usually works only if the patients also receive large doses of drugs designed to help immune cells multiply rapidly, and those drugs have life-threatening side effects. Now a team of MIT engineers has devised a way to deliver the necessary drugs by smuggling them on the backs of the cells sent in to fight the tumor. That way, the drugs reach only their intended targets, greatly reducing the risk to the patient.

16 Aug 2010

Avenue to Access provides free prescription-size tube of ZITHRANOL-RR to stable plaque psoriasis patients

During the month of August, people with a certain type of psoriasis have the chance to access free medicine through Avenue to Access. The program is designed to help individuals with mild-to-moderate stable plaque psoriasis access to a free prescription-size tube of ZITHRANOL-RR (anthralin, 1.2%) rapid release microcrystalline encapsulated cream.

16 Aug 2010

Use of estrogen alone does not increase lung cancer mortality in postmenopausal women: Study

Use of estrogen alone did not increase lung cancer mortality in postmenopausal women, according to a study published online August 13 in The Journal of the National Cancer Institute. In the Women's Health Initiative (WHI) trial, which consisted of several clinical trials on postmenopausal women, one study showed women with previous hysterectomy taking combined estrogen plus progestin therapy had a statistically significant increase in lung cancer mortality, but not incidence. Other studies with combined hormone therapy have had conflicting results. But the influence of estrogen alone was unclear.

16 Aug 2010

Mathematical model projects potential impact of current tools fighting malaria in Africa

Current tools for combating malaria, such as artemisinin-based combination therapy (ACT) and increasing coverage of long-lasting insecticide treated nets (LLINs) insecticide-treated bednets (ITN) "could dramatically reduce the burden of malignant malaria on parts of Africa if a comprehensive, sustained intervention programme were in place," according to a study published this week in PLoS Medicine, CORDIS News reports.

16 Aug 2010

Medical News

US WorldMeds announces acquisition of Solstice Neurosciences for $35M

Delegates explore agricultural cooperation, expanded ties at two-day China-Africa Agricultural Forum

Stockholders of Allscripts, Eclipsys approve fusion of two companies

FDA's labeling of Ella as 'Emergency Contraceptive' misleading, says FRC

MeCP2 protein regulates properties of psychostimulant drugs: Research

Medicare fraudsters shift targets a la "whack-a-mole"

Aeolus Pharmaceuticals second quarter 2010 net loss increases to $0.10 per share

Scientists replace human gene to preserve photoreceptor function in retinal degeneration

Allscripts commences public offering on behalf of Misys plc

Inovio Pharmaceuticals 2010 second quarter net loss decreases

National Mentor Holdings third-quarter revenue increases 6.1% to $259.7 million

Medicare disability recipient dies of brain tumor after having coverage interrupted

Nymox second-quarter net loss increases to $1.75 million

Insurers defend limited-benefit health policies in fight over proposed restrictions

Treatment for diabetics cost U.S. hospitals 25% more than stays for non-diabetics

Psychological stress in middle age can lead to dementia: Research

New T cell engineering approach can improve success rate of immune-cell therapies

Avenue to Access provides free prescription-size tube of ZITHRANOL-RR to stable plaque psoriasis patients

Use of estrogen alone does not increase lung cancer mortality in postmenopausal women: Study

Mathematical model projects potential impact of current tools fighting malaria in Africa

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News